carnitine has been researched along with HMN (Hereditary Motor Neuropathy) Proximal Type I in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krosschell, KJ | 2 |
| Kissel, JT | 2 |
| Townsend, EL | 1 |
| Simeone, SD | 1 |
| Zhang, RZ | 1 |
| Reyna, SP | 2 |
| Crawford, TO | 2 |
| Schroth, MK | 2 |
| Acsadi, G | 2 |
| Kishnani, PS | 1 |
| Von Kleist-Retzow, JC | 1 |
| Hero, B | 1 |
| D'Anjou, G | 2 |
| Smith, EC | 1 |
| Elsheikh, B | 2 |
| Simard, LR | 1 |
| Prior, TW | 1 |
| Scott, CB | 1 |
| Lasalle, B | 1 |
| Sakonju, A | 2 |
| Wirth, B | 1 |
| Swoboda, KJ | 2 |
| Lewelt, A | 1 |
| Scott, C | 1 |
| Maczulski, JA | 1 |
| Stoddard, GJ | 1 |
| Elovic, E | 1 |
| Tein, I | 1 |
| Sloane, AE | 1 |
| Donner, EJ | 1 |
| Lehotay, DC | 1 |
| Millington, DS | 1 |
| Kelley, RI | 1 |
2 trials available for carnitine and HMN (Hereditary Motor Neuropathy) Proximal Type I
| Article | Year |
|---|---|
Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I.
Topics: Action Potentials; Carnitine; Cohort Studies; Drug Therapy, Combination; Female; GABA Agents; Humans | 2018 |
Compound muscle action potential and motor function in children with spinal muscular atrophy.
Topics: Action Potentials; Adolescent; Carnitine; Child; Child, Preschool; Electromyography; Female; GABA Ag | 2010 |
1 other study available for carnitine and HMN (Hereditary Motor Neuropathy) Proximal Type I
| Article | Year |
|---|---|
Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetyl-CoA C-Acetyltransferase; Acetyl-CoA C-Acyltransferase; Carn | 1995 |